SUN PHARMA ADVANCED RESEARCH COMPANY
|
The Current P/S Ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is 78.22.
| Share Price | ₹128.1 | Feb 26,2026 |
| Market Cap | ₹4,156.8 Cr | |
| Sales-TTM | ₹53.1 Cr | TTM-Consolidated Results |
| Price/Sales | 78.22x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SUN PHARMA ADVANCED RESEARCH COMPANY
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹4,156.8 Cr] as on Feb 26,2026
(/) Sales [ ₹53.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 78.22x ]
Thus, for SUN PHARMA ADVANCED RESEARCH COMPANY , the investors are currently willing to pay '78.22 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUN PHARMA ADVANCED RESEARCH COMPANY !
The chart below summarizes the trend in P/S Ratio of SUN PHARMA ADVANCED RESEARCH COMPANY over the last five years.
Historical PS (Price/Sales) ratio chart of SUN PHARMA ADVANCED RESEARCH COMPANY
PS Ratio Performance Analysis for SUN PHARMA ADVANCED RESEARCH COMPANY
- SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio for fiscal years ending Mar2025 to Mar2023 averaged 83.41x.
- SUN PHARMA ADVANCED RESEARCH COMPANY 's operated at median p/e ratio of 66.93x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio peaked in Mar2024 at 158.92x.
- SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio hit its five-year low in Mar2023 of 24.39x.
How does SUN PHARMA ADVANCED RESEARCH COMPANY 's P/S Ratio benchmark against top 10 peers in Business Support Industry?
| Peer Comparison (Business Support Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SUN PHARMA ADVANCED RESEARCH COMPANY | 53.1 | 78.22 | 4,156.8 |
| SYNGENE INTERNATIONAL LTD | 3,720.2 | 4.61 | 17,149.1 |
| SAGILITY INDIA LTD | 6,737.1 | 2.81 | 18,912.6 |
| LATENT VIEW ANALYTICS LTD | 1,003.8 | 6.88 | 6,905.1 |
| JUST DIAL LTD | 1,042.9 | 4.72 | 4,918.6 |
| AWFIS SPACE SOLUTIONS LTD | 1,423.0 | 1.50 | 2,128.3 |
| MEDI ASSIST HEALTHCARE SERVICES LTD | 851.7 | 3.37 | 2,873.6 |
| JAYKAY ENTERPRISES LTD | 189.5 | 9.82 | 1,859.9 |
| ECOS (INDIA) MOBILITY & HOSPITALITY LTD | 778.6 | 1.16 | 906.0 |
| RK SWAMY LTD | 323.4 | 1.55 | 501.7 |
| KRYSTAL INTEGRATED SERVICES LTD | 1,325.4 | 0.66 | 873.3 |
Business Support Industry Benchmark (Top 10) PS Analysis vs SUN PHARMA ADVANCED RESEARCH COMPANY 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 0.66x |
| Max industry PS | 78.22x |
| Median industry PS | 3.37x |
| Average industry PS | 10.48x |
You may also like the below Video Courses